Human Papilloma Virus (HPV)NCT07110909
Impact of HPV Education on Knowledge, Awareness, and Concern
A study testing HPV Education in people with Human Papilloma Virus (HPV), run by Gizem ÇITAK at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled study is being conducted between January and April 2025 at a Family Health Center in the Black Sea Region with 103 women (intervention group: 50, control group: 53) selected via randomizer.org. Read more about this study
- Who is it for?
- Ages 18 to 49 years, women only
- Conditions the study is for
- Human Papilloma Virus (HPV)
- What is being tested?
- HPV Education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 103 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jan 2025to 2 Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 49 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Being a woman aged 18-49
- Not having received any previous education about HPV
- Volunteering to participate in the study and providing written consent
Who cannot join
- Having been diagnosed with HPV or being in treatment
- Having previously received information or counselling about HPV
- Refusing or withdrawing from the education and data collection process
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Tokat Gaziosmanpaşa University Rectorate General Secretariat Taşlıçiftlik Campus, 60250 Tokat/Central
Tokat Province, Center, 60250
About this study
Official title: Does HPV Education Affect Knowledge, Awareness, and Concern?
This randomized controlled study is being conducted between January and April 2025 at a Family Health Center in the Black Sea Region with 103 women (intervention group: 50, control group: 53) selected via randomizer.org. Participants complete pre-tests, receive HPV and cervical cancer prevention education, and take post-tests to evaluate the impact of the intervention.
Keywords: HPV, education, knowledge, awareness, midwife.
Read the detailed description
This study is designed as a randomized controlled trial aimed at evaluating the impact of educational interventions on HPV awareness, knowledge levels, and concerns among women. The research is being carried out at a Family Health Center in the Black Sea Region between January and April 2025. A total of 103 women have been selected through randomizer.org and assigned to either the intervention group (n=50) or control group (n=53).
Participants are initially assessed using a Personal Information Form, the HPV Knowledge Scale, and the HPV Awareness and Concern Scale. The intervention group receives structured education on HPV and cervical cancer prevention delivered by midwives and healthcare professionals. Post-tests are planned to assess potential changes in the measured variables. The study emphasizes the importance of healthcare-based education in improving public awareness and preventive health behaviors.
Keywords: HPV, education, knowledge, awareness, prevention, midwife, cervical cancer.
- Conditions
- Human Papilloma Virus (HPV)
- Being tested
- HPV Education
- Keywords
- HPV, education, knowledge level, awareness, midwife
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HPV EducationOther
HPV Education
| Study group | Role | What they receive |
|---|---|---|
| No HPV Education | No intervention | Control group without HPV education. |
| Experimental | Experimental | Participants received HPV education to increase awareness and prevention of cervical cancer Receives: Other: HPV Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
HPV Knowledge Increase
The increase in women's knowledge about HPV is measured using an HPV knowledge questionnaire. The questionnaire is scored from 0 to 20 points, with higher scores indicating greater knowledge.
Measured: 1 week
Secondary outcomes (1)
Increasing HPV awareness among women
HPV awareness among women is measured using the HPV Awareness Questionnaire, scored from 0 to 10. Higher scores indicate higher awareness of HPV.
Measured: 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Aug 2025
- Study start1 Jan 2025
- Primary completion1 Apr 2025
- Study completion2 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Human Papilloma Virus (HPV)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- experimental group: 50; control group: 53
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 103 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gizem ÇITAK
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Gizem ÇITAK, Tokat Gaziosmanpasa University
- Investigators
- GİZEM ÇITAK, Asist. Prof, Principal investigator, Tokat Gaziosmanpaşa University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07110909
- Sponsor's protocol ID
- K22.05
- Status last verified
- Aug 2025
- First submitted
- 28 Jul 2025
- Last updated
- 8 Aug 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The IPD will not be shared because the data include sensitive health information and participants did not consent to data sharing.
Study at a glance
From the registry record, last updated by the sponsor on 8 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does HPV Education Affect Knowledge, Awareness, and Concern?
- ClinicalTrials.gov ID
- NCT07110909
- Acronym / sponsor ID
- K22.05
- Conditions
- Human Papilloma Virus (HPV)
- Keywords
- HPV, education, knowledge level, awareness, midwife
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 103 participants (actual)
- Lead sponsor
- Gizem ÇITAKUniversity, hospital or other
- Study start
- 1 Jan 2025 (actual)
- Primary completion
- 1 Apr 2025 (actual)
- Study completion
- 2 Apr 2025 (actual)
- First posted
- 8 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled study is being conducted between January and April 2025 at a Family Health Center in the Black Sea Region with 103 women (intervention group: 50, control group: 53) selected via randomizer.org. Participants complete pre-tests, receive HPV and cervical cancer prevention education, and take post-tests to evaluate the impact of the intervention.
Keywords: HPV, education, knowledge, awareness, midwife.
Detailed description
This study is designed as a randomized controlled trial aimed at evaluating the impact of educational interventions on HPV awareness, knowledge levels, and concerns among women. The research is being carried out at a Family Health Center in the Black Sea Region between January and April 2025. A total of 103 women have been selected through randomizer.org and assigned to either the intervention group (n=50) or control group (n=53).
Participants are initially assessed using a Personal Information Form, the HPV Knowledge Scale, and the HPV Awareness and Concern Scale. The intervention group receives structured education on HPV and cervical cancer prevention delivered by midwives and healthcare professionals. Post-tests are planned to assess potential changes in the measured variables. The study emphasizes the importance of healthcare-based education in improving public awareness and preventive health behaviors.
Keywords: HPV, education, knowledge, awareness, prevention, midwife, cervical cancer.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- experimental group: 50; control group: 53
| Arm | Type | Receives |
|---|---|---|
| No HPV Education | No intervention | –Control group without HPV education. |
| Experimental | Experimental | Other: HPV EducationParticipants received HPV education to increase awareness and prevention of cervical cancer |
Who may qualify
- Ages
- 18 to 49 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Being a woman aged 18-49
- Not having received any previous education about HPV
- Volunteering to participate in the study and providing written consent
Key exclusion criteria (3 listed)
- Having been diagnosed with HPV or being in treatment
- Having previously received information or counselling about HPV
- Refusing or withdrawing from the education and data collection process
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HPV EducationHPV Education | Other | Experimental |
Primary outcome
HPV Knowledge Increase
Time frame: 1 week
The increase in women's knowledge about HPV is measured using an HPV knowledge questionnaire. The questionnaire is scored from 0 to 20 points, with higher scores indicating greater knowledge.
1 secondary outcome
Increasing HPV awareness among women
Time frame: 1 week
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Aug 2025.
- Individual participant dataSharing planned: No. The IPD will not be shared because the data include sensitive health information and participants did not consent to data sharing.
Related trials for Human Papilloma Virus (HPV)
Not yet recruitingPhase 1/2
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine
Human Papillomavirus Infection
Active, not recruitingPhase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Immunization, HPV Infection
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
RecruitingPhase 2
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection
RecruitingPhase 2
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Head and Neck Cancer, Head and Neck Squamous Cell Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
GİZEM ÇITAK, Asist. Prof principal investigator
Tokat Gaziosmanpaşa University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing HPV Education in people with Human Papilloma Virus (HPV), run by Gizem ÇITAK at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
HPV Knowledge Increase (time frame: 1 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2025.